• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Med Chem . Discovery of novel thiophene derivatives as potent neuraminidase inhibitors

tetano

Editor, Senior Moderator
Eur J Med Chem


. 2021 Aug 13;225:113762.
doi: 10.1016/j.ejmech.2021.113762. Online ahead of print.
Discovery of novel thiophene derivatives as potent neuraminidase inhibitors


Zhi Jian Zhong[SUP] 1 [/SUP], Xiao Tong Hu[SUP] 2 [/SUP], Li Ping Cheng[SUP] 3 [/SUP], Xing Yong Zhang[SUP] 1 [/SUP], Qiang Zhang[SUP] 4 [/SUP], Ju Zhang[SUP] 5 [/SUP]



Affiliations

Abstract

Neuraminidase (NA) is an important target for the treatment of influenza. In this study, a new lead NA inhibitor, 4 (ZINC01121127), was discovered by pharmacophore-based virtual screening and molecular dynamic (MD) simulation. Some novel NA inhibitors containing thiophene ring were synthesized by optimizing the skeleton of the lead compound 4. Compound 4b had the most potent inhibitory activity against NA (IC[SUB]50[/SUB] = 0.03 μM), which was better than the positive control oseltamivir carboxylate (IC[SUB]50[/SUB] = 0.06 μM). 4b (EC[SUB]50[/SUB] = 1.59 μM) also exhibits excellent antiviral activity against A/chicken/Hubei/327/2004 (H5N1-DW), which is superior to the reference drug OSC (EC[SUB]50[/SUB] = 5.97 μM). Molecular docking study shows that the thiophene moiety plays an essential role in compound 4b, which can bind well to the active site of NA. The good activity of 4b may be also ascribed to the extending of quinoline ring into the 150-cavity. The results of this study may provide an insightful help for the development of new NA inhibitors.

Keywords: 150-Cavity; Neuraminidase inhibitor; Thiophene; Virtual screening.
 
Back
Top Bottom